Severe relapse in a multiple sclerosis patient associated with ipilimumab treatment of melanoma.
Identifieur interne : 000314 ( Main/Exploration ); précédent : 000313; suivant : 000315Severe relapse in a multiple sclerosis patient associated with ipilimumab treatment of melanoma.
Auteurs : Edward J. Gettings [États-Unis] ; Christopher T. Hackett [États-Unis] ; Thomas F. ScottSource :
- Multiple sclerosis (Houndmills, Basingstoke, England) [ 1477-0970 ] ; 2015.
Descripteurs français
- KwdFr :
- Adulte d'âge moyen, Anticorps monoclonaux (effets indésirables), Anticorps monoclonaux (usage thérapeutique), Antinéoplasiques (effets indésirables), Antinéoplasiques (usage thérapeutique), Ataxie (étiologie), Humains, Mâle, Mélanome (), Mélanome (traitement médicamenteux), Parésie (étiologie), Récidive, Résultat thérapeutique, Sclérose en plaques récurrente-rémittente (), Troubles neurologiques de la marche (étiologie).
- MESH :
- effets indésirables : Anticorps monoclonaux, Antinéoplasiques.
- traitement médicamenteux : Mélanome.
- usage thérapeutique : Anticorps monoclonaux, Antinéoplasiques.
- étiologie : Ataxie, Parésie, Troubles neurologiques de la marche.
- Adulte d'âge moyen, Humains, Mâle, Mélanome, Récidive, Résultat thérapeutique, Sclérose en plaques récurrente-rémittente.
English descriptors
- KwdEn :
- Antibodies, Monoclonal (adverse effects), Antibodies, Monoclonal (therapeutic use), Antineoplastic Agents (adverse effects), Antineoplastic Agents (therapeutic use), Ataxia (etiology), Gait Disorders, Neurologic (etiology), Humans, Male, Melanoma (complications), Melanoma (drug therapy), Middle Aged, Multiple Sclerosis, Relapsing-Remitting (complications), Paresis (etiology), Recurrence, Treatment Outcome.
- MESH :
- chemical , adverse effects : Antibodies, Monoclonal, Antineoplastic Agents.
- chemical , therapeutic use : Antibodies, Monoclonal, Antineoplastic Agents.
- complications : Melanoma, Multiple Sclerosis, Relapsing-Remitting.
- drug therapy : Melanoma.
- etiology : Ataxia, Gait Disorders, Neurologic, Paresis.
- Humans, Male, Middle Aged, Recurrence, Treatment Outcome.
DOI: 10.1177/1352458514549403
PubMed: 25257614
Affiliations:
Links toward previous steps (curation, corpus...)
- to stream PubMed, to step Corpus: 000402
- to stream PubMed, to step Curation: 000402
- to stream PubMed, to step Checkpoint: 000402
- to stream Ncbi, to step Merge: 003754
- to stream Ncbi, to step Curation: 003754
- to stream Ncbi, to step Checkpoint: 003754
- to stream Main, to step Merge: 000314
- to stream Main, to step Curation: 000314
Le document en format XML
<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">Severe relapse in a multiple sclerosis patient associated with ipilimumab treatment of melanoma.</title><author><name sortKey="Gettings, Edward J" sort="Gettings, Edward J" uniqKey="Gettings E" first="Edward J" last="Gettings">Edward J. Gettings</name><affiliation wicri:level="3"><nlm:affiliation>Department of Neurology, Allegheny General Hospital, Pittsburgh, USA.</nlm:affiliation><country xml:lang="fr">États-Unis</country><wicri:regionArea>Department of Neurology, Allegheny General Hospital, Pittsburgh</wicri:regionArea><placeName><settlement type="city">Pittsburgh</settlement><region type="state">Pennsylvanie</region></placeName></affiliation></author><author><name sortKey="Hackett, Christopher T" sort="Hackett, Christopher T" uniqKey="Hackett C" first="Christopher T" last="Hackett">Christopher T. Hackett</name><affiliation wicri:level="3"><nlm:affiliation>Department of Neurology, Allegheny General Hospital, Pittsburgh, USA.</nlm:affiliation><country xml:lang="fr">États-Unis</country><wicri:regionArea>Department of Neurology, Allegheny General Hospital, Pittsburgh</wicri:regionArea><placeName><settlement type="city">Pittsburgh</settlement><region type="state">Pennsylvanie</region></placeName></affiliation></author><author><name sortKey="Scott, Thomas F" sort="Scott, Thomas F" uniqKey="Scott T" first="Thomas F" last="Scott">Thomas F. Scott</name><affiliation><nlm:affiliation>Department of Neurology, Allegheny General Hospital, Pittsburgh, USA Drexel University College of Medicine, Philadelphia, USA tscott@wpahs.org.</nlm:affiliation><wicri:noCountry code="subField">USA tscott@wpahs.org.</wicri:noCountry></affiliation></author></titleStmt><publicationStmt><idno type="wicri:source">PubMed</idno><date when="2015">2015</date><idno type="RBID">pubmed:25257614</idno><idno type="pmid">25257614</idno><idno type="doi">10.1177/1352458514549403</idno><idno type="wicri:Area/PubMed/Corpus">000402</idno><idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Corpus" wicri:corpus="PubMed">000402</idno><idno type="wicri:Area/PubMed/Curation">000402</idno><idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Curation">000402</idno><idno type="wicri:Area/PubMed/Checkpoint">000402</idno><idno type="wicri:explorRef" wicri:stream="Checkpoint" wicri:step="PubMed">000402</idno><idno type="wicri:Area/Ncbi/Merge">003754</idno><idno type="wicri:Area/Ncbi/Curation">003754</idno><idno type="wicri:Area/Ncbi/Checkpoint">003754</idno><idno type="wicri:Area/Main/Merge">000314</idno><idno type="wicri:Area/Main/Curation">000314</idno><idno type="wicri:Area/Main/Exploration">000314</idno></publicationStmt><sourceDesc><biblStruct><analytic><title xml:lang="en">Severe relapse in a multiple sclerosis patient associated with ipilimumab treatment of melanoma.</title><author><name sortKey="Gettings, Edward J" sort="Gettings, Edward J" uniqKey="Gettings E" first="Edward J" last="Gettings">Edward J. Gettings</name><affiliation wicri:level="3"><nlm:affiliation>Department of Neurology, Allegheny General Hospital, Pittsburgh, USA.</nlm:affiliation><country xml:lang="fr">États-Unis</country><wicri:regionArea>Department of Neurology, Allegheny General Hospital, Pittsburgh</wicri:regionArea><placeName><settlement type="city">Pittsburgh</settlement><region type="state">Pennsylvanie</region></placeName></affiliation></author><author><name sortKey="Hackett, Christopher T" sort="Hackett, Christopher T" uniqKey="Hackett C" first="Christopher T" last="Hackett">Christopher T. Hackett</name><affiliation wicri:level="3"><nlm:affiliation>Department of Neurology, Allegheny General Hospital, Pittsburgh, USA.</nlm:affiliation><country xml:lang="fr">États-Unis</country><wicri:regionArea>Department of Neurology, Allegheny General Hospital, Pittsburgh</wicri:regionArea><placeName><settlement type="city">Pittsburgh</settlement><region type="state">Pennsylvanie</region></placeName></affiliation></author><author><name sortKey="Scott, Thomas F" sort="Scott, Thomas F" uniqKey="Scott T" first="Thomas F" last="Scott">Thomas F. Scott</name><affiliation><nlm:affiliation>Department of Neurology, Allegheny General Hospital, Pittsburgh, USA Drexel University College of Medicine, Philadelphia, USA tscott@wpahs.org.</nlm:affiliation><wicri:noCountry code="subField">USA tscott@wpahs.org.</wicri:noCountry></affiliation></author></analytic><series><title level="j">Multiple sclerosis (Houndmills, Basingstoke, England)</title><idno type="eISSN">1477-0970</idno><imprint><date when="2015" type="published">2015</date></imprint></series></biblStruct></sourceDesc></fileDesc><profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Antibodies, Monoclonal (adverse effects)</term><term>Antibodies, Monoclonal (therapeutic use)</term><term>Antineoplastic Agents (adverse effects)</term><term>Antineoplastic Agents (therapeutic use)</term><term>Ataxia (etiology)</term><term>Gait Disorders, Neurologic (etiology)</term><term>Humans</term><term>Male</term><term>Melanoma (complications)</term><term>Melanoma (drug therapy)</term><term>Middle Aged</term><term>Multiple Sclerosis, Relapsing-Remitting (complications)</term><term>Paresis (etiology)</term><term>Recurrence</term><term>Treatment Outcome</term></keywords><keywords scheme="KwdFr" xml:lang="fr"><term>Adulte d'âge moyen</term><term>Anticorps monoclonaux (effets indésirables)</term><term>Anticorps monoclonaux (usage thérapeutique)</term><term>Antinéoplasiques (effets indésirables)</term><term>Antinéoplasiques (usage thérapeutique)</term><term>Ataxie (étiologie)</term><term>Humains</term><term>Mâle</term><term>Mélanome ()</term><term>Mélanome (traitement médicamenteux)</term><term>Parésie (étiologie)</term><term>Récidive</term><term>Résultat thérapeutique</term><term>Sclérose en plaques récurrente-rémittente ()</term><term>Troubles neurologiques de la marche (étiologie)</term></keywords><keywords scheme="MESH" type="chemical" qualifier="adverse effects" xml:lang="en"><term>Antibodies, Monoclonal</term><term>Antineoplastic Agents</term></keywords><keywords scheme="MESH" type="chemical" qualifier="therapeutic use" xml:lang="en"><term>Antibodies, Monoclonal</term><term>Antineoplastic Agents</term></keywords><keywords scheme="MESH" qualifier="complications" xml:lang="en"><term>Melanoma</term><term>Multiple Sclerosis, Relapsing-Remitting</term></keywords><keywords scheme="MESH" qualifier="drug therapy" xml:lang="en"><term>Melanoma</term></keywords><keywords scheme="MESH" qualifier="effets indésirables" xml:lang="fr"><term>Anticorps monoclonaux</term><term>Antinéoplasiques</term></keywords><keywords scheme="MESH" qualifier="etiology" xml:lang="en"><term>Ataxia</term><term>Gait Disorders, Neurologic</term><term>Paresis</term></keywords><keywords scheme="MESH" qualifier="traitement médicamenteux" xml:lang="fr"><term>Mélanome</term></keywords><keywords scheme="MESH" qualifier="usage thérapeutique" xml:lang="fr"><term>Anticorps monoclonaux</term><term>Antinéoplasiques</term></keywords><keywords scheme="MESH" qualifier="étiologie" xml:lang="fr"><term>Ataxie</term><term>Parésie</term><term>Troubles neurologiques de la marche</term></keywords><keywords scheme="MESH" xml:lang="en"><term>Humans</term><term>Male</term><term>Middle Aged</term><term>Recurrence</term><term>Treatment Outcome</term></keywords><keywords scheme="MESH" xml:lang="fr"><term>Adulte d'âge moyen</term><term>Humains</term><term>Mâle</term><term>Mélanome</term><term>Récidive</term><term>Résultat thérapeutique</term><term>Sclérose en plaques récurrente-rémittente</term></keywords></textClass></profileDesc></teiHeader></TEI><affiliations><list><country><li>États-Unis</li></country><region><li>Pennsylvanie</li></region><settlement><li>Pittsburgh</li></settlement></list><tree><noCountry><name sortKey="Scott, Thomas F" sort="Scott, Thomas F" uniqKey="Scott T" first="Thomas F" last="Scott">Thomas F. Scott</name></noCountry><country name="États-Unis"><region name="Pennsylvanie"><name sortKey="Gettings, Edward J" sort="Gettings, Edward J" uniqKey="Gettings E" first="Edward J" last="Gettings">Edward J. Gettings</name></region><name sortKey="Hackett, Christopher T" sort="Hackett, Christopher T" uniqKey="Hackett C" first="Christopher T" last="Hackett">Christopher T. Hackett</name></country></tree></affiliations></record>Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Wicri/Amérique/explor/PittsburghV1/Data/Main/Exploration
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000314 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd -nk 000314 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Wicri/Amérique
|area= PittsburghV1
|flux= Main
|étape= Exploration
|type= RBID
|clé= pubmed:25257614
|texte= Severe relapse in a multiple sclerosis patient associated with ipilimumab treatment of melanoma.
}}
Pour générer des pages wiki
HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/RBID.i -Sk "pubmed:25257614" \
| HfdSelect -Kh $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd \
| NlmPubMed2Wicri -a PittsburghV1
| This area was generated with Dilib version V0.6.38. |  |